1. EP2 Antagonists (2011–2021): A Decade’s Journey from Discovery to Therapeutics
   Madison N. Sluter et al, 2021, Journal of Medicinal Chemistry CrossRef
2. Biological Evaluation, Molecular Docking Analyses, and ADME Profiling of Certain New Quinazolinones as Anti-colorectal Agents
   Nahed N. E. El-Sayed et al, 2022, ACS Omega CrossRef
3. Small Molecule Compounds of Natural Origin Target Cellular Receptors to Inhibit Cancer Development and Progression
   Jinhua Wang et al, 2022, International Journal of Molecular Sciences CrossRef
4. The Multifaceted Role of GPCRs in Amyotrophic Lateral Sclerosis: A New Therapeutic Perspective?
   Davide Bassani et al, 2022, International Journal of Molecular Sciences CrossRef
5. Induction of p53-Dependent Apoptosis by Prostaglandin A2
   Su-Been Lee et al, 2020, Biomolecules CrossRef
6. Hydroethanolic Leaf Extract of Cordia vignei Hutch and Dalziel Inhibits Carrageenan-Induced Foot Oedema in Chicks, Prostaglandin E2-Induced Paw Oedema in Mice, and Bradykinin-Induced Paw Oedema in Mice
   George Owusu et al, 2023, Evidence-Based Complementary and Alternative Medicine CrossRef
7. Phosphatidylcholine-Derived Lipid Mediators: The Crosstalk Between Cancer Cells and Immune Cells
   Renata de Freitas Saito et al, 2022, Frontiers in Immunology CrossRef
8. Natural Inhibitors against Potential Targets of Cyclooxygenase, Lipoxygenase and Leukotrienes
   Anil Kumar Saxena et al, 2022, Combinatorial Chemistry & High Throughput Screening CrossRef
9. The constitutive activity of the viral-encoded G protein-coupled receptor US28 supports a complex signalling network contributing to cancer development
   Carole A. Daly et al, 2020, Biochemical Society Transactions CrossRef
10. Prodigiosin/celecoxib-loaded into zein/sodium caseinate nanoparticles as a potential therapy for triple negative breast cancer
    Wafaa A. Mohamed et al, 2024, Scientific Reports CrossRef
11. The role of EP-2 receptor expression in cervical intraepithelial neoplasia
    Elisa Schmoeckel et al, 2020, Histochemistry and Cell Biology CrossRef
12. Combination of EP 4 antagonist MF-766 and anti-PD-1 promotes anti-tumor efficacy by modulating both lymphocytes and myeloid cells
    Yun Wang et al, 2021, OncoImmunology CrossRef
13. An Update on the Anticancer Activity of Xanthone Derivatives: A Review
    Yehezkiel Steven Kurniawan et al, 2021, Pharmaceuticals CrossRef